Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay

Chronic Lymphocytic Leukemia (CLL) is a heterogeneous disease characterized by variable clinical courses among different patients. This notion was supported by the possible coexistence of two or more independent CLL clones within the same patients, identified by the characterization of the B cell re...

Full description

Bibliographic Details
Main Authors:	Selena Mimmi, Domenico Maisano, Vincenzo Dattilo, Massimo Gentile, Federico Chiurazzi, Alessandro D’Ambrosio, Annamaria Zimbo, Nancy Nisticò, Annamaria Aloisio, Eleonora Vecchio, Giuseppe Fiume, Enrico Iaccino, Ileana Quinto
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Biomedicines
Subjects:	B-cells chronic lymphocytic leukemia gene expression analysis CLL heterogeneity B-lymphoproliferative disorders phage display
Online Access:	https://www.mdpi.com/2227-9059/10/3/604

Similar Items

Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival
by: Nancy Nisticò, et al.
Published: (2020-09-01)

Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations
by: Domenico Maisano, et al.
Published: (2021-06-01)

Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity
by: Electra Sofou, et al.
Published: (2022-12-01)

Advocating the need of a systems biology approach for personalised prognosis and treatment of B-CLL patients
by: Hemanth Tummala, et al.
Published: (2012-12-01)

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
by: Uffe Klausen, et al.
Published: (2022-11-01)

Insights about MYC and Apoptosis in B-Lymphomagenesis: An Update from Murine Models
by: Eleonora Vecchio, et al.
Published: (2020-06-01)

The regulatory capacity of B cells directs the aggressiveness of CLL
by: Audrey Mohr, et al.
Published: (2019-03-01)

Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy
by: Annamaria Aloisio, et al.
Published: (2021-04-01)

The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter
by: Jingyu Deng, et al.
Published: (2014-01-01)

Ibrutinib dose modifications in the management of CLL
by: Camille Hardy-Abeloos, et al.
Published: (2020-06-01)

Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?
by: Beyhan Durak Aras, et al.
Published: (2021-01-01)

Cytokine Release Ensuing Interaction Between Human Peripheral Blood Mononuclears and Epstein-Barr Virus Transformed B-CLL Cell Line
by: Hanna Bessler, et al.
Published: (2020-08-01)

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
by: Ujjani C, et al.
Published: (2020-08-01)

Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL
by: Gonzalo Blanco, et al.
Published: (2018-06-01)

NF-kB and the CLL microenvironment
by: Alice O’Donnell, et al.
Published: (2023-03-01)

<i>ICOS</i> gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population
by: Irena Frydecka, et al.
Published: (2011-04-01)

Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling
by: Evan A. Mulligan, et al.
Published: (2023-09-01)

Challenges in Diagnosis and Clinical Management of COVID-19 in Patient with B-Cell Chronic Lymphocytic Leukemia (CLL): Report of One Case
by: Vincenzo Visco, et al.
Published: (2022-03-01)

Students’ Perception on The Implementation of Orai Application In CLL Method in Teaching Speaking
by: Halimah, et al.
Published: (2022-05-01)

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial
by: Alexander Egle, et al.
Published: (2019-04-01)

The Influence of CLL on EFL Learners’ Speaking Skill
by: Muhammad Ilyas
Published: (2018-08-01)

The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome
by: Arancha Rodríguez-Caballero, et al.
Published: (2021-10-01)

CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring
by: Stefano Vergani, et al.
Published: (2023-03-01)

The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia
by: Alessandro Noto, et al.
Published: (2021-05-01)

Proteomics and Drug Repurposing in CLL towards Precision Medicine
by: Dimitra Mavridou, et al.
Published: (2021-07-01)

Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring
by: Domenico Maisano, et al.
Published: (2020-08-01)

Review of Venetoclax in CLL, AML and Multiple Myeloma
by: Masa Lasica, et al.
Published: (2021-05-01)

Emerging Therapies in CLL in the Era of Precision Medicine
by: Prajish Iyer, et al.
Published: (2023-03-01)

Engineering extracellular vesicles as novel treatment options: exploiting herpesviral immunity in CLL
by: Kathrin Gärtner, et al.
Published: (2019-12-01)

Modification of immunocytochemical ZAP-70 assay for potential clinical application in B-cell chronic lymphocytic leukemia
by: Jerzy Kawiak, et al.
Published: (2011-08-01)

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV(mut) and IgHV(unmut) subgroups
by: Burns, A, et al.
Published: (2017)

Altered DNA Methylation Profiles in <i>SF3B1</i> Mutated CLL Patients
by: Alicja Pacholewska, et al.
Published: (2021-08-01)

Critical molecular pathways in CLL therapy
by: Gerardo Ferrer, et al.
Published: (2018-03-01)

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia
by: Matthew Kaufman, et al.
Published: (2022-07-01)

IBtkα Activates the β-Catenin-Dependent Transcription of <i>MYC</i> through Ubiquitylation and Proteasomal Degradation of GSK3β in Cancerous B Cells
by: Eleonora Vecchio, et al.
Published: (2022-02-01)

B cell M-CLL clones retain selection against replacement mutations in their immunoglobulin gene framework regions
by: Hadas Neuman, et al.
Published: (2023-03-01)

Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements
by: Davide Bagnara, et al.
Published: (2022-06-01)

Current strategies for the diagnosis and management of chronic lymphocytic leukemia (CLL), with a focus on poor-risk CLL: A review
by: Fabienne Mc Clanahan, et al.
Published: (2011-05-01)

Current strategies for the diagnosis and management of chronic lymphocytic leukemia (CLL), with a focus on poor-risk CLL: A review
by: Fabienne Mc Clanahan, et al.
Published: (2011-06-01)

Celebrating 20 Years of IGHV Mutation Analysis in CLL
by: Nicholas Chiorazzi, et al.
Published: (2020-02-01)